share_log

DEF 14A: Definitive information statements

DEF 14A: Definitive information statements

DEF 14A:股東委託書決議
美股SEC公告 ·  11/04 21:04

牛牛AI助理已提取核心訊息

SeaStar Medical Holding Corporation, a Delaware corporation, has announced a 2024 Special Meeting of Stockholders to be held virtually on November 26, 2024. The meeting will address three key proposals: the ratification of the issuance of shares upon conversion of convertible notes and exercise of warrants (the Nasdaq Proposal), an amendment to the Certificate of Incorporation to reduce the number of authorized shares of common stock by 50,000,000 to 450,000,000 shares (the Authorized Share Proposal), and a proposal to adjourn or postpone the Special Meeting if necessary (the Adjournment Proposal). The Nasdaq Proposal seeks to maintain the company's listing on the Nasdaq Stock Market following the issuance of additional shares beyond what was initially approved by stockholders, due to amendments to a Securities Purchase...Show More
SeaStar Medical Holding Corporation, a Delaware corporation, has announced a 2024 Special Meeting of Stockholders to be held virtually on November 26, 2024. The meeting will address three key proposals: the ratification of the issuance of shares upon conversion of convertible notes and exercise of warrants (the Nasdaq Proposal), an amendment to the Certificate of Incorporation to reduce the number of authorized shares of common stock by 50,000,000 to 450,000,000 shares (the Authorized Share Proposal), and a proposal to adjourn or postpone the Special Meeting if necessary (the Adjournment Proposal). The Nasdaq Proposal seeks to maintain the company's listing on the Nasdaq Stock Market following the issuance of additional shares beyond what was initially approved by stockholders, due to amendments to a Securities Purchase Agreement. The Authorized Share Proposal aims to reduce the authorized shares of common stock, which would decrease the company's Delaware franchise tax obligations and potentially prevent dilution of existing stockholders' shares. The Adjournment Proposal would allow the Board of Directors to adjourn the meeting to a later date if there are insufficient votes for the other proposals. The Board of Directors unanimously recommends voting FOR all three proposals.
SeaStar Medical Holding Corporation,一家特拉華州公司,已宣佈將於2024年11月26日虛擬舉行2024年股東特別大會。大會將討論三項關鍵提案:批准根據可轉換票據轉股和行使認股權發行股份(納斯達克提案),修改公司章程以將普通股授權股份數量減少5,000萬至4.5億股(授權股份提案),以及如有必要將特別會議延期或推遲的提案(延期提案)。納斯達克提案旨在公司發行超出股東最初批准的額外股份後,繼續保持在納斯達克證券交易所的上市地位,這是由於對證券購買協議的修訂。授權股份提案旨在減少普通股授權股份,從而降低公司特拉華州特許稅的義務,並可能防止現有股東股份的稀釋。延期提案將允許董事會在其他提案缺乏足夠支持票數時將會議延期至以後的日期。董事會一致建議投票贊成所有三項提案。
SeaStar Medical Holding Corporation,一家特拉華州公司,已宣佈將於2024年11月26日虛擬舉行2024年股東特別大會。大會將討論三項關鍵提案:批准根據可轉換票據轉股和行使認股權發行股份(納斯達克提案),修改公司章程以將普通股授權股份數量減少5,000萬至4.5億股(授權股份提案),以及如有必要將特別會議延期或推遲的提案(延期提案)。納斯達克提案旨在公司發行超出股東最初批准的額外股份後,繼續保持在納斯達克證券交易所的上市地位,這是由於對證券購買協議的修訂。授權股份提案旨在減少普通股授權股份,從而降低公司特拉華州特許稅的義務,並可能防止現有股東股份的稀釋。延期提案將允許董事會在其他提案缺乏足夠支持票數時將會議延期至以後的日期。董事會一致建議投票贊成所有三項提案。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。